부산대학교 도서관

HLA class II genes (DRB, DQA, DQB, DPA, and DPB) were typed at the DNA level using polymerase chain reaction/sequence-specfic oligonnucleotide probe analysis in 78 unrelated patients with DCM and 336 unrelated healthy controls to elucidate the HLA alleles or HLA haplotypes associated with DCM. The frequencies of DRB&1401 (14.4% v4.5%, RR = 3.90, P<0.0005, Pc<0.03), DQB1*0503 (14.1% v5.4%, RR=2.93, P<0.007) and DRB1*1401-DQB1*0503 haplotype (11.5% v1.5%, RR = 8.24, P<0.00001, Pc<0.01) were increased in the DCM patients. The frequency of HLA-DRB1*1101 (9.0% v3.0%, RR = 3.26, P<0.02) also was increased in the patients. In addition, the frequencies of DQB1*0604 and DPB1*0401 were increased in the DRB1*1401 and DRB1*1101 negative patients. In contrast, the frequencies of DQB1*0303 (19.2% v30.7%, RR = 0.55, P<0.05) and DRB1*0901-DQB1*0.03 haplotype (16.7% v29.8%, RR = 0.49, P<0.02) were decreased in the DCM group. Disease susceptibility to DCM in the Japanese population, thus, may be controlled in part by a gene (or genes) in close linkage disequilibrium with DRB1*1401-DQB1*0503, DRB1*1101-DQB1*0301, and DQB1*0604-DPB1*0401 haplotypes, while the resistance to DCM may be associated with the DRB1*0901-DQB1*0303 haplotype.